RT Book, Section
A1 Wilson, James M.
A1 Willerson, James T.
A2 Cohn, Lawrence H.
SR Print(0)
ID 55916761
T1 Chapter 20. Myocardial Revascularization with Percutaneous Devices
T2 Cardiac Surgery in the Adult, 4e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-163310-9
LK accesssurgery.mhmedical.com/content.aspx?aid=55916761
RD 2024/04/19
AB At  its  height,  the  popularity  of  surgical  coronary  revascularization  spurred  improvement  in  catheter-based  technology—first  for  imaging  quality  and  later  for  attempted  therapy.  In  1974,  Andreas  Gruentzig  completed  development  of  the  double-lumen  balloon  catheter  that  was  miniaturized  for  use  in  coronary  arteries.  Soon  afterward,  techniques  for  percutaneous  transluminal  coronary  angioplasty  (PTCA)  expanded  as  technical  breakthroughs  were  applied  to  subselective  catheters,  devices,  guidewires,  balloon  materials,  and  lastly,  coronary  stents.  Presently  trial  evidence  attests  that  percutaneous  therapy  is  useful  as  a  treatment  in  patients  with  unacceptably  controlled  angina  whose  anatomy  does  not  imply  a  survival  benefit  from  revascularization  or  for  patients  with  uncontrollable,  unstable  symptoms.  However,  surgical  and  percutaneous  revascularization  cannot  be  considered  equivalent.1